Miniglucagon (Glucagon 19–29), a Potent and Efficient Inhibitor of Secretagogue-induced Insulin Release through a Ca2+Pathway
Open Access
- 1 April 1999
- journal article
- Published by Elsevier
- Vol. 274 (16) , 10869-10876
- https://doi.org/10.1074/jbc.274.16.10869
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Electrophysiological and Metabolic Characterization of Single β-Cells and Islets From Diabetic GK RatsDiabetes, 1998
- Preproglucagon and Its ProcessingPublished by Springer Nature ,1996
- Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal isletsDiabetologia, 1993
- Permeation and gating properties of the L-type calcium channel in mouse pancreatic beta cells.The Journal of general physiology, 1993
- FACTORS AFFECTING THE SENSITIVITY OF AN IMMUNORADIOMETRIC ASSAY FOR ADRENOCORTICOTROPIC HORMONE Biomedical Research, 1992
- Miniglucagon [glucagon-(19-29)] is a component of the positive inotropic effect of glucagonAmerican Journal of Physiology-Cell Physiology, 1991
- Proteolytic events in the post-translational processing of polypeptide hormone precursorsBiochimie, 1987
- A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagonNature, 1987
- Proteases and posttranslational processing of prohormones: a reviewCanadian Journal of Biochemistry and Cell Biology, 1983
- Post-Translational Proteolysis in Polypeptide Hormone BiosynthesisAnnual Review of Physiology, 1982